Florentina E Sileanu1, Raghavan Murugan2, Nicole Lucko2, Gilles Clermont3, Sandra L Kane-Gill4, Steven M Handler5, John A Kellum6. 1. Center for Critical Care Nephrology and Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, Departments of Critical Care Medicine and Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania; and. 2. Center for Critical Care Nephrology and Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, Departments of Critical Care Medicine and. 3. Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, Departments of Critical Care Medicine and. 4. Center for Critical Care Nephrology and Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania. 5. Center for Critical Care Nephrology and Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; 6. Center for Critical Care Nephrology and Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, Departments of Critical Care Medicine and kellumja@upmc.edu.
Abstract
BACKGROUND AND OBJECTIVES: AKI in critically ill patients is usually part of multiorgan failure. However, nonrenal organ failure may not always precede AKI and patients without evidence of these organ failures may not be at low risk for AKI. This study examined the risk and outcomes associated with AKI in critically ill patients with and without cardiovascular or respiratory organ failures at presentation to the intensive care unit (ICU). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A large, academic medical center database, with records from July 2000 through October 2008, was used and the authors identified a low-risk cohort as patients without cardiovascular and respiratory organ failures defined as not receiving vasopressor support or mechanical ventilation within the first 24 hours of ICU admission. AKI was defined using Kidney Disease Improving Global Outcomes criteria. The primary end points were moderate to severe AKI (stages 2-3) and risk-adjusted hospital mortality. RESULTS: Of 40,152 critically ill patients, 44.9% received neither vasopressors nor mechanical ventilation on ICU day 1. Stages 2-3 AKI occurred less frequently in the low-risk patients versus high-risk patients within 24 hours (14.3% versus 29.1%) and within 1 week (25.7% versus 51.7%) of ICU admission. Patients developing AKI in both risk groups had higher risk of death before hospital discharge. However, the adjusted odds of hospital mortality were greater (odds ratio, 2.99; 95% confidence interval, 2.62 to 3.41) when AKI occurred in low-risk patients compared with those with respiratory or cardiovascular failures (odds ratio, 1.19; 95% confidence interval, 1.09 to 1.3); interaction P<0.001. CONCLUSIONS: Patients admitted to ICU without respiratory or cardiovascular failure have a substantial likelihood of developing AKI. Although survival for low-risk patients is better than for high-risk patients, the relative increase in mortality associated with AKI is actually greater for low-risk patients. Strategies aimed at preventing AKI should not exclude ICU patients without cardiovascular or respiratory organ failures.
BACKGROUND AND OBJECTIVES: AKI in critically illpatients is usually part of multiorgan failure. However, nonrenal organ failure may not always precede AKI and patients without evidence of these organ failures may not be at low risk for AKI. This study examined the risk and outcomes associated with AKI in critically illpatients with and without cardiovascular or respiratory organ failures at presentation to the intensive care unit (ICU). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A large, academic medical center database, with records from July 2000 through October 2008, was used and the authors identified a low-risk cohort as patients without cardiovascular and respiratory organ failures defined as not receiving vasopressor support or mechanical ventilation within the first 24 hours of ICU admission. AKI was defined using Kidney Disease Improving Global Outcomes criteria. The primary end points were moderate to severe AKI (stages 2-3) and risk-adjusted hospital mortality. RESULTS: Of 40,152 critically illpatients, 44.9% received neither vasopressors nor mechanical ventilation on ICU day 1. Stages 2-3 AKI occurred less frequently in the low-risk patients versus high-risk patients within 24 hours (14.3% versus 29.1%) and within 1 week (25.7% versus 51.7%) of ICU admission. Patients developing AKI in both risk groups had higher risk of death before hospital discharge. However, the adjusted odds of hospital mortality were greater (odds ratio, 2.99; 95% confidence interval, 2.62 to 3.41) when AKI occurred in low-risk patients compared with those with respiratory or cardiovascular failures (odds ratio, 1.19; 95% confidence interval, 1.09 to 1.3); interaction P<0.001. CONCLUSIONS:Patients admitted to ICU without respiratory or cardiovascular failure have a substantial likelihood of developing AKI. Although survival for low-risk patients is better than for high-risk patients, the relative increase in mortality associated with AKI is actually greater for low-risk patients. Strategies aimed at preventing AKI should not exclude ICU patients without cardiovascular or respiratory organ failures.
Authors: Michael Haase; Prasad Devarajan; Anja Haase-Fielitz; Rinaldo Bellomo; Dinna N Cruz; Gebhard Wagener; Catherine D Krawczeski; Jay L Koyner; Patrick Murray; Michael Zappitelli; Stuart L Goldstein; Konstantinos Makris; Claudio Ronco; Johan Martensson; Claes-Roland Martling; Per Venge; Edward Siew; Lorraine B Ware; T Alp Ikizler; Peter R Mertens Journal: J Am Coll Cardiol Date: 2011-04-26 Impact factor: 24.094
Authors: Kirsten Colpaert; Eric A Hoste; Kristof Steurbaut; Dominique Benoit; Sofie Van Hoecke; Filip De Turck; Johan Decruyenaere Journal: Crit Care Med Date: 2012-04 Impact factor: 7.598
Authors: Xiaoxi Zeng; Gearoid M McMahon; Steven M Brunelli; David W Bates; Sushrut S Waikar Journal: Clin J Am Soc Nephrol Date: 2013-10-31 Impact factor: 8.237
Authors: G J Kuperman; J M Teich; M J Tanasijevic; N Ma'Luf; E Rittenberg; A Jha; J Fiskio; J Winkelman; D W Bates Journal: J Am Med Inform Assoc Date: 1999 Nov-Dec Impact factor: 4.497
Authors: Sandra L Kane-Gill; Shyam Visweswaran; Melissa I Saul; An-Kwok Ian Wong; Louis E Penrod; Steven M Handler Journal: Int J Med Inform Date: 2011-05-31 Impact factor: 4.046
Authors: David C Classen; Roger Resar; Frances Griffin; Frank Federico; Terri Frankel; Nancy Kimmel; John C Whittington; Allan Frankel; Andrew Seger; Brent C James Journal: Health Aff (Millwood) Date: 2011-04 Impact factor: 6.301
Authors: Ayan Sen; Christopher M Keener; Florentina E Sileanu; Emily Foldes; Gilles Clermont; Raghavan Murugan; John A Kellum Journal: Crit Care Med Date: 2017-02 Impact factor: 7.598
Authors: John A Kellum; Florentina E Sileanu; Raghavan Murugan; Nicole Lucko; Andrew D Shaw; Gilles Clermont Journal: J Am Soc Nephrol Date: 2015-01-07 Impact factor: 10.121
Authors: Kelly V Liang; Florentina E Sileanu; Gilles Clermont; Raghavan Murugan; Francis Pike; Paul M Palevsky; John A Kellum Journal: Clin J Am Soc Nephrol Date: 2015-12-17 Impact factor: 8.237
Authors: John Danziger; Ken P Chen; Joon Lee; Mengling Feng; Roger G Mark; Leo Anthony Celi; Kenneth J Mukamal Journal: Crit Care Med Date: 2016-02 Impact factor: 7.598